The Level of Preoperative Plasma KRAS Mutations and CEA Predict Survival of Patients Undergoing Surgery for Colorectal Cancer Liver Metastases
出版年份 2020 全文链接
标题
The Level of Preoperative Plasma KRAS Mutations and CEA Predict Survival of Patients Undergoing Surgery for Colorectal Cancer Liver Metastases
作者
关键词
-
出版物
Cancers
Volume 12, Issue 9, Pages 2434
出版商
MDPI AG
发表日期
2020-08-27
DOI
10.3390/cancers12092434
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Clinical significance and diagnostic value of serum NSE, CEA, CA19‑9, CA125 and CA242 levels in colorectal cancer
- (2020) Hai Luo et al. Oncology Letters
- Temporal and spatial effects and survival outcomes associated with concordance between tissue and blood KRAS alterations in the pan‐cancer setting
- (2019) Kristina Mardinian et al. INTERNATIONAL JOURNAL OF CANCER
- Plasma microRNA Levels Combined with CEA and CA19-9 in the Follow-Up of Colorectal Cancer Patients
- (2019) Martin Pesta et al. Cancers
- The prognostic value of the postoperative serum CEA levels/preoperative serum CEA levels ratio in colorectal cancer patients with high preoperative serum CEA levels
- (2019) Hai-Lun Xie et al. Cancer Management and Research
- Colorectal cancer liver metastases – a population-based study on incidence, management and survival
- (2018) Jennie Engstrand et al. BMC CANCER
- Serum-derived carcinoembryonic antigen (CEA) activates fibroblasts to induce a local re-modeling of the extracellular matrix that favors the engraftment of CEA-expressing tumor cells
- (2018) Aws Abdul-Wahid et al. INTERNATIONAL JOURNAL OF CANCER
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Liquid biopsy and multiparametric analysis in management of liver malignancies: new concepts of the patient stratification and prognostic approach
- (2018) Olga Golubnitschaja et al. EPMA Journal
- Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer
- (2018) Jesús García-Foncillas et al. BRITISH JOURNAL OF CANCER
- Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review
- (2018) Veronika Vymetalkova et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- On the Dual Role of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (CEACAM1) in Human Malignancies
- (2018) Andreea Calinescu et al. Journal of Immunology Research
- Blood-based detection ofRASmutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-basedRAStesting
- (2017) Wolff Schmiegel et al. Molecular Oncology
- Factors Requiring Adjustment in the Interpretation of Serum Carcinoembryonic Antigen: A Cross-Sectional Study of 18,131 Healthy Nonsmokers
- (2017) Hae Yeon Kang et al. Gastroenterology Research and Practice
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
- (2016) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care
- (2016) S. El Messaoudi et al. CLINICAL CANCER RESEARCH
- RECIST 1.1—Update and clarification: From the RECIST committee
- (2016) Lawrence H. Schwartz et al. EUROPEAN JOURNAL OF CANCER
- ExtendedRASGene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015
- (2016) Carmen J. Allegra et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer
- (2015) M. Peeters et al. CLINICAL CANCER RESEARCH
- Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery
- (2015) Thomas Reinert et al. GUT
- Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment andRASMutations in Colorectal Cancer
- (2015) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
- (2015) Giulia Siravegna et al. NATURE MEDICINE
- The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation
- (2015) Paola Carpinetti et al. Oncotarget
- Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer
- (2015) Karen Lise Garm Spindler et al. PLoS One
- KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer
- (2014) Jian-Ming Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Free circulating DNA as a biomarker of colorectal cancer
- (2014) Elisa Cassinotti et al. International Journal of Surgery
- KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer
- (2013) K G Spindler et al. BRITISH JOURNAL OF CANCER
- Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features
- (2013) Christophe Rosty et al. MODERN PATHOLOGY
- Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
- (2013) Jean-Yves Douillard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Quantitative Cell-Free DNA, KRAS, and BRAF Mutations in Plasma from Patients with Metastatic Colorectal Cancer during Treatment with Cetuximab and Irinotecan
- (2012) K.-L. G. Spindler et al. CLINICAL CANCER RESEARCH
- KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients
- (2011) N Knijn et al. BRITISH JOURNAL OF CANCER
- Serum Carcinoembryonic Antigen Monitoring After Curative Resection for Colorectal Cancer: Clinical Significance of the Preoperative Level
- (2009) In Ja Park et al. ANNALS OF SURGICAL ONCOLOGY
- Implications for KRAS status and EGFR-targeted therapies in metastatic CRC
- (2009) Nicola Normanno et al. Nature Reviews Clinical Oncology
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer
- (2008) Emile Tan et al. SURGICAL ONCOLOGY-OXFORD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation